[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information
In this section...
On this site...

Hepatitis B Vaccine and the prevetion of Hepatocellular Carcinoma

Smith Kline Beecham have announced their hepatitis B vaccine recombinant (Engerix B) and claimed it to be the first anti-cancer vaccine. Whilst this claim may be thought to be unjustified by most doctors, nevertheless, it is true that hepatitis B infection is causally related to the development of hepatocellular carcinoma in many patients and so its prevention will decrease the incidence of the disease.